Comparison of the effects of alfentanil or sufentanil combined with target-controlled infusion of propofol for ambulatory hysteroscopic surgery

Comparison of the effects of alfentanil or sufentanil combined with target-controlled infusion of propofol forambulatory hysteroscopic surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200063939

Enrollment

Unknown

Registered

2022-09-21

Start date

2022-10-01

Completion date

Unknown

Last updated

2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group A:alfentainl analgesia

Group S:sufentanil analgesia

Eligibility

Sex/Gender

Female

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Accurate and complete clinical data; 2. Aged 18-60 years, ASA grade ?-?, BMI 19-29Kg/m^2; 3. Ability to read and understand; 4. Know about this study, volunteer to participate.

Exclusion criteria

Exclusion criteria: 1. A history of opioid allergy; 2. Long-term history of chronic pain or long-term use of opioids, non-steroidal anti-inflammatory drugs, psychiatric drugs; 3. Addiction to tobacco, alcohol or other drugs; 4. There is pathological obesity or obstructive sleep apnea syndrome (OSAS).

Design outcomes

Primary

Measure	Time frame
Overall incidence of adverse events;	—

Secondary

Measure	Time frame
Perioperative vital signs;Total dosage of propofol;Wake-up time;Operator's degree of satisfaction;	—

Countries

China

Contacts

Public ContactHuang Xuezhu

Chongqing Health Center for Women and Children (Women and Children's Hospital of Chongqing Medical University)

huang_xuezhu@126.com+86 15922578738

Outcome results